The Valley Desk

NCT04447469 · Interventional trial

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Overall registry status Completed

Phase 2 · Phase 3

Conditions COVID

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov